Survey identifies specialty-based differences in CDI management

• by Julia Cipriano

• August 24, 2026

Decreased Antimicrobial Resistance Gene Richness Following Fecal Microbiota, Live-jslm (REBYOTA®) Administration: Post Hoc Analysis of PUNCH CD3

• by Elizabeth Adamowicz, Colleen S Kraft, Tonya Ward, Nirja Mehta, William D Shannon, Rohan Mishra, Ken F Blount

• July 2, 2025

Sepsis Antibiotic Timing Shows Physician Divide

Emergency department physicians differ in how quickly they initiate antibiotics for suspected sepsis.

• by Kathryn Wighton

• March 2, 2026

• 4 min

Oral Carbapenem Wins FDA Approval for cUTIs

Tebipenem pivoxil was noninferior to intravenous imipenem-cilastatin in hospitalized adults.

• by Kathryn Wighton

• June 17, 2026

• 2 min